Literature DB >> 7570294

Treatment of delayed-type hypersensitivity with inhibitors of the VLA-4 integrin.

S Tamraz1, T Arrhenius, A Chiem, M J Forrest, F C Gaeta, Y B He, J Lei, A Maewal, M L Phillips, L W Vollger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7570294     DOI： 10.1007/BF00196099

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  34 in total

1.  Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo.

Authors:  T B Issekutz
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

Review 2.  Circulating adhesion molecules in disease.

Authors:  A J Gearing; W Newman
Journal:  Immunol Today       Date:  1993-10

Review 3.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation.

Authors:  T B Issekutz
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

5.  Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion.

Authors:  M J Humphries; S K Akiyama; A Komoriya; K Olden; K M Yamada
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

6.  Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo.

Authors:  T A Ferguson; H Mizutani; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

7.  Recruitment of lymphocytes during cutaneous delayed hypersensitivity in nonhuman primates is dependent on E-selectin and vascular cell adhesion molecule 1.

Authors:  A Silber; W Newman; V G Sasseville; D Pauley; D Beall; D G Walsh; D J Ringler
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

8.  Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.

Authors:  W M Abraham; M W Sielczak; A Ahmed; A Cortes; I T Lauredo; J Kim; B Pepinsky; C D Benjamin; D R Leone; R R Lobb
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis.

Authors:  K Miyake; I L Weissman; J S Greenberger; P W Kincade
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.

Authors:  E A Wayner; A Garcia-Pardo; M J Humphries; J A McDonald; W G Carter
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539
View more
  2 in total

1.  Anti-inflammatory activity of c(ILDV-NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesion.

Authors:  D Haworth; A Rees; P J Alcock; L J Wood; A S Dutta; J J Gormley; H B Jones; A Jamieson; C F Reilly
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Blockade of integrin VLA-4 prevents inflammation and matrix metalloproteinase expression in a murine model of accelerated collagen-induced arthritis.

Authors:  Anil Raychaudhuri; Mary Chou; Marla Weetall; Arco Y Jeng
Journal:  Inflammation       Date:  2003-04       Impact factor: 4.092
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.